secwatch.observer — SEC 8-K summary
======================================

Issuer:     CONMED Corp (CNMD)
CIK:        0000816956
Form:       8-K
Filed at:   2026-05-20T12:30:27+00:00
Accession:  0000816956-26-000057
Event type: leadership
Sentiment:  positive
Materiality: 0.50
Item codes: 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CONMED appoints two new directors from J&J and Boston Scientific; Board expands to nine
--------------------------------------------------------------------------------

- Appointed Celine Martin (ex-J&J MedTech exec) and Jeff Mirviss (ex-Boston Scientific exec) to Board, effective July 1, 2026.
- Martin to serve on Audit and Strategy Committees; Mirviss on Compensation and Governance Committees.
- Appointed Kimberly Lockwood as Interim Corporate Controller and Principal Accounting Officer, effective June 1, 2026.
- Stockholders elected seven directors, approved say-on-pay, and ratified PwC as auditor for fiscal 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/816956/000081695626000057/0000816956-26-000057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/816956/000081695626000057/cnmd-20260518.htm
  HTML page:      https://secwatch.observer/filing/0000816956-26-000057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer